Document is current
Any future updates will be listed below
-
Authors
Arsenijevic, Yvan https://orcid.org/0000-0001-6960-1291
Chang, Ning https://orcid.org/0000-0002-3501-6454
Mercey, Olivier
El Fersioui, Younes
Koskiniemi-Kuendig, Hanna
Joubert, Caroline
Bemelmans, Alexis-Pierre https://orcid.org/0000-0001-7605-5225
Rivolta, Carlo https://orcid.org/0000-0002-0733-9950
Banin, Eyal
Sharon, Dror
Guichard, Paul https://orcid.org/0000-0002-0363-1049
Hamel, Virginie https://orcid.org/0000-0001-5092-2343
Kostic, Corinne https://orcid.org/0000-0003-1006-9733
-
Funding
Funding for this research was provided by:
SNF | Swiss National Centre of Competence in Research Kidney Control of Homeostasis (CRSII3_141814)
Foundation Provisu
Foundation "En souvenir du Dr Georges Borel"
Fondation Asiles des Aveugles
Novartis Stiftung für Medizinisch-Biologische Forschung
- License Information
-
More Information
Article History
Received: 10 January 2024
Revised: 28 February 2024
Accepted: 28 February 2024
First Online: 19 March 2024
Disclosure and competing interests statement
: YA, CK, NC, and DS are inventors of a patent pending “GENE THERAPY FOR FAM161A-ASSOCIATED RETINOPATHIES AND OTHER CILIOPATHIES” (PCT/EP2023/069304). Otherwise no other financial competing interests exist for this study.
